Avoid common mistakes on your manuscript.
The generation of insulin-producing cells from differentiating mouse embryonic stem (ES) cells was described some years ago [1], but subsequent studies could not replicate the results. Instead, using the same differentiation protocol, it was found that insulin immunoreactivity occurred as a consequence of insulin uptake from the medium [2], neuronal cells were formed [2–4], or insulin was released as an artefact from differentiated ES cells [2, 3]. Functional pancreatic cells, however, were successfully generated using lineage selection strategies based on pancreas-specific promoters [5, 6], by modified protocols in combination with transgene expression [7–9], or by addition of a phosphoinositol-3 kinase inhibitor [10]. The differentiated cells showed properties of (neonatal) beta cells, such as insulin transcripts and C-peptide/insulin co-expression, insulin-secretory granules, ion channel activity of embryonal beta cells, and normalisation of blood glucose level after transplantation into diabetic mice [5–10]. Most of the differentiation protocols required a long cultivation period, including 4–5 days of embryoid body (EB) formation, followed by 3–4 weeks of differentiation, and some protocols required genetic manipulation. Recently, a relatively short procedure of pancreatic differentiation by a three-step experimental approach was published [11]. The strategy is based on the combined treatment by activin A, all-trans-retinoic acid, and other factors such as basic fibroblast growth factor (bFGF), which induced murine ES cells to differentiate into insulin-producing cells within 2 weeks. The authors presented results on insulin transcripts, C-peptide/insulin co-expression, glucose-induced insulin release, and the normalisation of glycaemia following transplantation into diabetic mice.
Neuronal vs pancreatic differentiation in vivo and of ES cells in vitro
On looking more closely at the C-peptide-positive cells differentiated according to the protocol of Shi et al. [11], it became obvious that both pancreatic and neuronal differentiation had been induced. In part, the clusters showed the typical morphology of grape-like structures, but also neuronal cell types (Fig. 1a). Immunohistochemical stainings revealed varying levels of co-expression of C-peptide, a byproduct of pro-insulin synthesis (used as a marker for insulin-producing cells), and the neuron-specific beta-III tubulin (Fig. 1b–g). Such ectoderm-derived insulin-producing (C-peptide-positive) cells have been generated from ES cells via EB formation, as well as from monolayer cultures following exposure to pancreatic differentiation factors (see [12]).
Similarities between pancreatic beta cells and neurons have long been known (Table 1). During embryogenesis in vivo, the same transcription factors regulate both neuroectoderm and pancreatic differentiation processes in a spatially and temporally controlled manner. During pancreatic differentiation, neurog3 mRNA has been detected in pancreatic buds as early as embryonic day (E) 9.5 [13] and the neurog3 protein has been found at E11.5 in epithelial cells of the pancreatic buds [14]. Similar expression patterns were described for Pax6 and Isl1 ([13], for review see [15]). In parallel, during neuronal and glial cell development, Isl1, Pax6, and neurog3 mRNA and proteins could be detected as early as E10.5, when neurogenesis begins ([16, 17], see Table 1). It has also been found that the intermediate filament protein nestin—suggested as marker of neural stem or progenitor cells—is transiently produced during neuronal [18] and pancreatic [1, 7–9, 19] differentiation of ES cells, respectively (see [19–22]).
In contrast to embryogenesis, pancreas-specific transcription factors are not expressed in a spatially controlled pattern during ES cell differentiation in vitro. As a consequence, exogenously applied activin A would induce ES cells to differentiate in parallel into pancreatic beta-like cells and into neuronal phenotypes (see Fig. 1). Previous studies have shown that activin A induces the formation of neuronal extensions and neurofilament proteins in PC12 cells [23] and enhances the activity of neuron-specific L-type Ca2+ channels in neuroblastoma cells [24], suggesting the involvement of activin A in neural differentiation. Consequently, activin A treatment in ES-derived EBs containing a population of multi-lineage progenitor cells will induce neuroectodermal progenitors into neural phenotypes, and endoderm progenitors into pancreatic phenotypes. A more sophisticated application schedule of activin A treatment and serum removal is clearly necessary to enrich endoderm progenitor cells, as recently presented by D’Amour et al. [25]. Neuronal cells, however, were not analysed in this study.
Major differences between endoderm- and ectoderm-derived insulin-producing cells are based on different functions of insulin. In ectodermal cells, insulin acts as a growth factor, whereas in endoderm-derived pancreatic tissues, insulin is involved in hormonal regulation of nutrient homeostasis. Due to these different functions, two main problems arise with the generation of ectoderm-derived insulin-producing cells in tissue culture systems: (1) the level of insulin release is much lower than that of pancreatic beta cells; and (2) release is not regulated by high glucose levels. Glucose-responsive insulin-producing cells generated from brain-derived human neural progenitor cells released 0.5–1% of the C-peptide level secreted by beta cells of the pancreas [26]. Application of such cell populations for transplantation purposes remains questionable and insufficient.
Role of nestin in epithelial–mesenchymal transitions during in vitro differentiation?
Another aspect important for the development of pancreatic cells is epithelial–mesenchymal transition (EMT) [27, 28]. Pancreas development and, in particular, exocrine differentiation, are critically dependent on the presence of factors secreted from mesenchyme [29–31]. Follistatin and fibroblast growth factors represent some of the key mesenchymal factors that actively promote pancreatic development [32–34]. In addition, in the endocrine compartment of the developing pancreas, glucagon and glucagon-like peptide 1-producing alpha cells play an important role in the differentiation of early insulin-producing cells [35]. All these signalling factors have specific functions in pancreas development, but will also be important for pancreatic differentiation of ES cells [36]. Moreover, soluble factors of the blood vessel endothelium within the islets of Langerhans are known to induce endocrine pancreas development [37], and the participation of the vascular endothelium is necessary to regulate hormonal interactions between cells of the islets. It has been postulated that it is not only epithelial–mesenchymal and intra-epithelial interactions, but also endothelial–mesenchymal transitions that may play a role in proper pancreas development [21, 31].
There has been speculation that nestin expression/re-expression is involved in these processes [20]. Following in vitro culture, nestin and vimentin are formed as a consequence of EMT-dedifferentiation into ‘stem-like’ mesenchymal cells (see [21]). This would imply that nestin cannot be regarded as a tissue-specific marker, but plays a general role in maintaining stem/progenitor cell properties by unequal partitioning of cytoplasmic components during cell division (see [38]). The finding that nestin-positive cells are generally formed in early differentiated ES cell derivatives in vitro [20], however, requires culture conditions that do not lead to the differentiation induction of neuronal cell types.
In summary, whereas present studies show that ES-derived pancreatic cells produce and release insulin in response to high glucose concentrations in functional assays, the differentiated cell clusters do not currently represent islets (see [39]). Neuronal cells are present, whereas endothelial cells are not integrated into islet-like clusters. As a next step, it will be necessary not only to establish efficient ES cell differentiation strategies to increase the yield of insulin expression, synthesis and release, but also to avoid the presence of artificially developed cell types in the islet-like clusters.
Abbreviations
- E:
-
embryonal day
- EB:
-
embryoid body
- EMT:
-
epithelial–mesenchymal transition
- ES:
-
embryonic stem
References
Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389–1394
Rajagopal J, Anderson WJ, Kume S, Martinez OI, Melton DA (2003) Insulin staining of ES cell progeny from insulin uptake. Science 299:363
Hansson M, Tonning A, Frandsen U et al (2004) Artifactual insulin release from differentiated embryonic stem cells. Diabetes 53:2603–2609
Sipione S, Eshpeter A, Lyon JG, Korbutt GS, Bleackley RC (2004) Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia 47:499–508
Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA, Martin F (2000) Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49:157–162
Leon-Quinto T, Jones J, Skoudy A, Burcin M, Soria B (2004) In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia 47:1442–1451
Blyszczuk P, Czyz J, Kania G et al (2003) Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci USA 100:998–1003
Blyszczuk P, Asbrand C, Rozzo A et al (2004) Embryonic stem cells differentiate into insulin-producing cells without selection of nestin-expressing cells. Int J Dev Biol 48:1095–1104
Schroeder IS, Rolletschek A, Blyszczuk P, Kania G, Wobus AM (2006) Differentiation of mouse embryonic stem cells to insulin-producing cells. Nature Protoc 1:495–507
Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK (2002) Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci USA 99:16105–16110
Shi Y, Hou L, Tang F et al (2005) Inducing embryonic stem cells to differentiate into pancreatic β cells by a novel three-step approach with activin a and all-trans retinoic acid. Stem Cells 23:656–662
Roche E, Sepulcre P, Reig JA, Santana A, Soria B (2005) Ectodermal commitment of insulin-producing cells derived from mouse embryonic stem cells. FASEB J 19:1341–1343
Gradwohl G, Dierich A, LeMeur M, Guillemot F (2000) Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 97:1607–1611
Schwitzgebel VM, Scheel DW, Conners JR et al (2000) Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 127:3533–3542
Habener JF, Kemp DM, Thomas MK (2005) Minireview: Transcriptional regulation in pancreatic development. Endocrinology 146:1025–1034
Nakagawa Y, O’Leary DDM (2001) Combinatorial expression patterns of LIM-homeodomain and other regulatory genes parcellate developing thalamus. J Neurosci 21:2711–2725
Lee J, Wu Y, Qi Y et al (2003) Neurogenin3 participates in gliogenesis in the developing vertebrate spinal cord. Dev Biol 253:84–98
Okabe S, Forsberg-Nilsson K, Spiro AC, Segal M, McKay RD (1996) Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech Dev 59:89–102
Kania G, Blyszczuk P, Wobus AM (2004) The generation of insulin-producing cells from embryonic stem cells — a discussion of controversial findings. Int J Dev Biol 48:1061–1064
Wiese C, Rolletschek A, Kania G et al (2004) Nestin expression—a property of multi-lineage progenitor cells? Cell Mol Life Sci 61:2510–2522
Habener JF (2004) A perspective on pancreatic stem/progenitor cells. Pediatr Diabetes 5[Suppl 2]:29–37
Wobus AM, Boheler KR (2005) Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85:635–678
Iwasaki S, Hattori A, Sato M, Tsujimoto M, Kohno M (1996) Characterization of the bone morphogenetic protein-2 as a neurotrophic factor. Induction of neuronal differentiation of PC12 cells in the absence of mitogen-activated protein kinase activation. J Biol Chem 271:17360–17365
Fukuhara S, Mukai H, Munekata E (1997) Activin A and all-trans-retinoic acid cooperatively enhanced the functional activity of L-type Ca2+ channels in the neuroblastoma C1300 cell line. Biochem Biophys Res Commun 241:363–368
D’Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE (2005) Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23: 1491–1492
Hori Y, Gu X, Xie X, Kim SK (2005) Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med 2:e103
Golosow N, Grobstein C (1962) Epitheliomesenchymal interaction in pancreatic morphogenesis. Dev Biol 4:242–255
Thiery JP (2003) Epithelial–mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740–746
Gittes GK, Galante PE, Hanahan D, Rutter WJ, Debase HT (1996) Lineage-specific morphogenesis in the developing pancreas: role of mesenchymal factors. Development 122:439–447
Edlund H (2002) Pancreatic organogenesis — developmental mechanisms and implications for therapy. Nat Rev Genet 3:524–532
Bonner-Weir S, Weir GC (2005) New sources of pancreatic beta-cells. Nat Biotechnol 23:857–861
Miralles F, Czernichow P, Scharfmann R (1998) Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development. Development 125:1017–1024
Miralles F, Czernichow P, Ozaki K, Itoh N, Scharfmann R (1999) Signaling through fibroblast growth factor receptor 2b plays a key role in the development of the exocrine pancreas. Proc Natl Acad Sci USA 96:6267–6272
Le Bras S, Miralles F, Basmaciogullari A, Czernichow P, Scharfmann R (1998) Fibroblast growth factor 2 promotes pancreatic epithelial cell proliferation via functional fibroblast growth factor receptors during embryonic life. Diabetes 47:1236–1242
Prasadan K, Daume E, Preuett B et al (2002) Glucagon is required for early insulin-positive differentiation in the developing mouse pancreas. Diabetes 51:3229–3236
Bai L, Meredith G, Tuch BE (2005) Glucagon-like peptide-1 enhances production of insulin in insulin-producing cells derived from mouse embryonic stem cells. J Endocrinol 186:343–352
Lammert E, Cleaver O, Melton D (2001) Induction of pancreatic differentiation by signals from blood vessels. Science 294:564–567
Chou YH, Khuon S, Herrmann H, Goldman RD (2003) Nestin promotes the phosphorylation-dependent disassembly of vimentin intermediate filaments during mitosis. Mol Biol Cell 14:1468–1478
Serup P (2006) Embryonic stem cell-based diabetes therapy—a long road to travel. Diabetologia. DOI 10.1007/s00125-006-0434-x
Rolletschek A, Chang H, Guan K, Czyz J, Meyer M, Wobus AM (2001) Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech Dev 105:93–104
Ahlgren U, Pfaff SL, Jessell TM, Edlund T, Edlund H (1997) Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 385:257–260
St Onge L, Sosa-Pineda B, Chowdhury K, Mansouri A, Gruss P (1997) Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 387:406–409
Sosa-Pineda B, Chowdhury K, Torres M, Oliver G, Gruss P (1997) The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 386:399–402
Lukinius A, Stridsberg M, Wilander E (2003) Cellular expression and specific intragranular localization of chromogranin A, chromogranin B, and synaptophysin during ontogeny of pancreatic islet cells: an ultrastructural study. Pancreas 27:38–46
Rosa P, Hille A, Lee RW, Zanini A, De Camilli P, Huttner WB (1985) Secretogranins I and II: two tyrosine-sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway. J Cell Biol 101:1999–2011
Gould VE, Lee I, Wiedenmann B, Moll R, Chejfec G, Franke WW (1986) Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms. Hum Pathol 17:979–983
Iturriza FC, Thibault J (1993) Immunohistochemical investigation of tyrosine-hydroxylase in the islets of Langerhans of adult mice, rats and guinea pigs. Neuroendocrinology 57:476–480
Kaufman S (1995) Tyrosine hydroxylase. Adv Enzymol Relat Areas Mol Biol 70:103–220
Squires PE, Churamani D, Pararajasingam R, Persaud SJ, Jones PM (2005) Similarities of KATP channel expression and Ca2+ changes in pancreatic beta cells and hypothalamic neurons. Pancreas 30:227–232
Le Gurun S, Martin D, Formenton A et al (2003) Connexin-36 contributes to control function of insulin-producing cells. J Biol Chem 278:37690–37697
Condorelli DF, Parenti R, Spinella F et al (1998) Cloning of a new gap junction gene (Cx36) highly expressed in mammalian brain neurons. Eur J Neurosci 10:1202–1208
Lendahl U, Zimmerman LB, McKay RD (1990) CNS stem cells express a new class of intermediate filament protein. Cell 60:585–595
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rolletschek, A., Kania, G. & Wobus, A.M. Generation of pancreatic insulin-producing cells from embryonic stem cells — ‘Proof of principle’, but questions still unanswered. Diabetologia 49, 2541–2545 (2006). https://doi.org/10.1007/s00125-006-0441-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-006-0441-y